Anthropic has rolled out a healthcare-focused version of its Claude chatbot, launching just days after OpenAI introduced a similar product, intensifying competition to bring generative AI into the medical sector.
Announced alongside the JPMorgan Healthcare Conference in San Francisco, Claude for Healthcare allows U.S. users on Anthropic’s Pro and Max plans to link personal health records for tailored medical insights. The move mirrors OpenAI’s ChatGPT Health rollout on January 7, which quickly gained traction among millions seeking health-related advice.
Both AI labs are relying on established health data partners to ensure secure record access. Anthropic teamed up with HealthEx, which connects to over 50,000 health systems, while OpenAI uses b.well, linked to more than 2 million providers and 320 health plans. Users can also integrate wellness apps like Apple Health and MyFitnessPal for holistic health tracking.
For providers and researchers, Anthropic built HIPAA-ready infrastructure alongside access to key medical databases such as CMS Coverage, ICD-10, PubMed, and the National Provider Identifier Registry. The tools aim to automate prior authorization processes and clinical documentation. Major healthcare organizations including AstraZeneca, Sanofi, and Banner Health are early partners.
Still, privacy concerns persist. Despite assurances that health data won’t train models and all conversations remain encrypted, experts warn that consumer-facing AI health tools may fall outside HIPAA protections. “These tools are incredibly potent,” said Eric Kauderer-Abrams, who leads Anthropic’s life sciences division. “However, for critical scenarios, users should always verify the information.”
